Zheng Quan Zhi Xing·2025-08-21 16:58Core Viewpoint - The legal opinion letter from Zhong Lun Law Firm confirms that the adjustments and cancellations related to the 2023 A-share restricted stock incentive plan of Kanglong Chemical (Beijing) Co., Ltd. have received the necessary approvals and comply with relevant laws and regulations [2][9]. Summary by Sections Legal Opinion Overview - The legal opinion was issued based on a service contract between Kanglong Chemical and Zhong Lun Law Firm, with the firm acting as legal counsel for the 2023 A-share restricted stock incentive plan [3][7]. - The lawyers reviewed various documents related to the incentive plan and verified facts through public information from government departments [3][9]. Approval and Authorization - The adjustments and cancellations of the incentive plan have been approved by the company's board and shareholders, including the independent directors who provided their opinions [8][9]. - The company has authorized the board to manage and adjust the incentive plan as per the resolutions passed in the shareholder meetings [9]. Specifics of Adjustments - The adjustment of the grant price for the incentive plan was made following the completion of the company's 2024 annual equity distribution, with a cash dividend of 2 yuan per 10 shares declared [9]. - The adjusted grant price is in accordance with the relevant regulations and the incentive plan [9]. Specifics of Cancellations - A total of 634,880 shares of restricted stock that were granted but not vested have been canceled due to the failure to meet performance targets and the disqualification of certain incentive recipients [11]. - The cancellation aligns with the provisions of the incentive plan and relevant regulations [11].